Home » Newsletters » BioWorld Science

BioWorld Science

July 22, 1997

View Archived Issues

DepoTech issued U.S. patents covering DepoFoam technology

Company Profile: VidaMed

Immunex: Q2 1997 highlights

Pfizer: Q2 1997 highlights

Use of NK3 antagonists in various disorders claimed by SKB

Immunosuppressant peptides from Ajinomoto

Novel fibrinogen/integrin receptor antagonists described by Merck KGaA

Steroids from Jenapharm for contraception/HRT

Pylorid introduced in Argentina

Maternal infection associated with increased risk for cerebral palsy in term infants

Mitsubishi Chemical R&D status in Japan and overseas

Vyrex establishes proof of principle for CD-Tagging in human cells

Kyowa Hakko/Yoshitomi launch Imagenil in Japan

Prograf to be submitted in Japan for atopic dermatitis

Takeda's Atacand scheduled for European launch later this year

Toray/Daiichi codevelop analgesic

Mitsui Pharmaceuticals pipeline update

Genentech: Q2 1997 highlights

Bristol-Myers Squibb and GBF to discover lead anticancer compounds

Celltech: six-month highlights

U.S. patent allowance for Cypress Bioscience's IPM product

New biotechnology company focuses on RNA targets for infectious diseases

RPR seeks approval for Menorest in Japan

D1/D2 combination therapy results reported at the 16th IDF congress

Economics of diabetes discussed at IDF 97

Hyperglycemia increases the risk of cardiovascular disease: epidemiological evidence

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...